Innovation
191 patent families (110 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 21,066 times.
| Year | Filings |
|---|---|
| 2015 | 48 |
| 2016 | 61 |
| 2017 | 52 |
| 2018 | 55 |
| 2019 | 69 |
| 2020 | 60 |
| 2021 | 41 |
| 2022 | 24 |
| 2023 | 24 |
| 2024 | 26 |
| 2025 | 23 |
| 2026 | 4 |
Social engagement
Social engagement: 48.7K social following, 9 posts in the last 12 months — below the industry typical range.
Investor mix
11 investors on record; 2 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 45% |
| Private equity | 4 | 36% |
| Bank & private debt | 1 | 9% |
| Other / undisclosed | 1 | 9% |
Hiring activity
Hires occasionally
2 roles tracked across 1 of the last 12 months
10 Jun 2026 · Senior Manager, Facilities · Raleigh
10 Jun 2026 · Director, Quality Control · Raleigh
11 Oct 2025 · Director, Development Program Management · New York
11 Sep 2025 · Manager, CSV · Raleigh
29 Jul 2025 · Manufacturing Operations Associate II · Raleigh
Based on job postings tracked across public sources.
Recent activity
20 May 2026
Event
Celelectis Annual Shareholders General Meeting
13 May 2026
Event
ASGCT 2026
12 May 2026
Event
European Hematology Association (EHA) 2026 congress